Traumatic Brain Injury Market Size and Forecast 2024-2033| Pfizer Inc., Medtronic PLC, Eli Lilly and Company, Stryker Corporation, Elekta AB

Overview and Scope

Traumatic brain injury (TBI) is a type of injury that occurs due to a sudden and external force applied to the head, causing brain damage. The common causes of traumatic brain injuries include falls, automobile accidents, sports-related injuries and violence or military combat incidents. Treating traumatic brain injuries involves a multidisciplinary approach, including medical interventions, rehabilitation and cognitive therapy.

Sizing and Forecast

The traumatic brain injury market size has grown strongly in recent years. It will grow from $2.48 billion in 2023 to $2.72 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%.  The  growth in the historic period can be attributed to improved trauma care, rehabilitation therapies, concussion awareness, military and sports research.

The traumatic brain injury market size is expected to see strong growth in the next few years. It will grow to $3.8 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%.  The growth in the forecast period can be attributed to neuroprotective agents, telemedicine and remote monitoring, individualized treatment plans, neuroinflammation research. Major trends in the forecast period include neurorehabilitation advances, mild tbi and concussion management, biomarker and imaging research, cognitive and emotional support.

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/traumatic-brain-injury-global-market-report

Segmentation & Regional Insights

The traumatic brain injury market covered in this report is segmented –

1) By Device: Computed Tomography; X-Ray; Imaging Devices; Magnetic Resonance Imaging Devices; Monitoring Devices; Other Devices

2) By Technique: Intracranial Pressure (ICP) Monitoring; Partial Pressure Of Oxygen In Brain Tissue (PbrO2)

3) By End-Use: Diagnostic Centers; Hospitals; Other End-Uses

North America was the largest region in the traumatic brain injury market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in traumatic brain injury market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13049&type=smp

Major Driver Impacting Market Growth

The rising road injuries are expected to propel the growth of the traumatic brain injury market going forward. Road injuries refer to any physical harm or damage due to incidents on roads, streets, highways, or other transportation routes. Traumatic brain injuries are often caused by road accidents, resulting in a wide range of physical and cognitive challenges for individuals affected by these incidents. Traumatic brain injury (TBI) treatment helps patients suffering from brain injuries caused by sudden road accidents with improved physical recovery, reduced complications and enhanced cognitive function. For instance, in September 2022, according to a report shared by Government Digital Service, a UK-based government body, approximately 1,558 people were killed in documented road traffic crashes in 2021, up 7% from 2020. Therefore, the rising road injuries are driving the growth of the traumatic brain injury market.

Key Industry Players

Major players in the traumatic brain injury market are  Pfizer Inc., Medtronic PLC, Eli Lilly and Company, Stryker Corporation, Elekta AB, Integra LifeSciences Holdings Corp., Natus Medical Inc., Nihon Kohden Corporation, Raumedic AG, Qure.ai, Compumedics Ltd., Synaptive Medical Inc., BrainScope Company Inc., Neuren Pharmaceuticals Limited, SanBio Co. Ltd., Soterix Medical Inc., Inteprod LLC, BioDirection Inc., InfraScan Inc., NanoDx Inc., NeuroTrauma Sciences, Oculogica Inc., PathMaker Neurosystems Inc., Pinteon Therapeutics Inc., Vivonics Inc., Neural Analytics Inc., ReNetX Bio Inc., Sana Health Inc., Abliva AB, QuesGen Systems Inc.

The traumatic brain injury market report table of contents includes:

1. Executive Summary

2. Traumatic Brain Injury Market Characteristics

3. Traumatic Brain Injury Market Trends And Strategies

4. Traumatic Brain Injury Market – Macro Economic Scenario

5. Global Traumatic Brain Injury Market Size and Growth

.

.

.

26. South America Traumatic Brain Injury Market

27. Brazil Traumatic Brain Injury Market

28. Middle East Traumatic Brain Injury Market

29. Africa Traumatic Brain Injury Market

30. Traumatic Brain Injury Market Competitive Landscape And Company Profiles

Top Major Players:

  • Pfizer Inc
  • Medtronic PLC
  • Eli Lilly and Company
  • Stryker Corporation
  • Elekta AB

Explore the trending research reports from TBRC:

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model